Amoxicillin–clavulanic acid: Antimicrobial Activity, Susceptibility, Administration and Dosage etc.
Amoxicillin–clavulanic acid (co-amoxiclav) is a combination product consisting of the semisynthetic antibiotic amoxicillin with the beta-lactamase inhibitor clavulanic acid as a potassium salt.
Mar 18，2022 API
Tazobactam: Antimicrobial Activity, Susceptibility, Administration and Dosage, Clinical Uses etc.
Being a beta-lactamase inhibitor, tazobactam is synergistic with many beta-lactamaselabile drugs, such as penicillin G, ampicillin, or piperacillin against many bacterial species which produce beta-l
Mar 18，2022 InhibitorsWhat is SR9009?
SR9009 is a REV-ERB agonist that increases the constitutive repression of genes regulated by REV-ERBα and REV-ERBβ with IC50 values of 670 and 800 nM, respectively.
Mar 18，2022 Inhibitors
Sulbactam: Antimicrobial Activity, Susceptibility, Administration and Dosage, Clinical Uses etc.
Sulbactam sodium is a semisynthetic beta-lactamase inhibitor obtained by oxidation of the thiazolidine sulfur of penicillanic acid (English et al., 1978).
Mar 18，2022 API
Removal and application of silicone oil
Silicone oils generally refer to linear polysiloxane products that remain liquid at room temperature.
Mar 18，2022 API
The importance of lithium hexafluorophosphate in the chemical industry
Lithium hexafluorophosphate is an inorganic substance with the chemical formula LiPF6, white crystal or powder.
Mar 18，2022 API
The application of ethylene glycol
Ethylene glycol is also known as "ethylene glycol", "1,2-ethylene glycol", or EG for short.
Mar 18，2022 APIWhat is Minocycline?
Minocycline is mainly marketed for oral administration, but a more soluble formulation of minocycline is available in some countries for parenteral administration.
Mar 17，2022 APIA second-generation tetracycline---Doxycycline
Doxycycline (alpha-6-deoxytetracycline) is a second-generation tetracycline with increased oral bioavailability and tissue penetration as a result of its improved lipophilicity compared with earlier t
Mar 17，2022 APIMechanism of action of Tetracycline
Tetracycline was first described in 1953 and was prepared from chlortetracycline at Lederle Laboratories, and was also independently derived from oxytetracycline at Pfizer Laboratories.
Mar 17，2022 API